Cyber police found multiple violations of personal information protection law, Xinhua report says, in first major case since ...

Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...

Protecting your data is a lot like your security practices. But legacy applications are no longer sufficient in this evolving digital transformation era. Some say now is the time to move on from ...

Engineers are beginning to understand the causes of silent data errors (SDEs) and the data center failures they cause, both of which can be reduced by increasing test coverage and boosting inspection ...

This round enables Castellum.AI to integrate more deeply with financial institutions, enabling compliance teams to quickly access our secure, effective and explainable AI. NEW YORK--(BUSINESS ...

Nearly a million women will receive a letter from the Dutch Population Screen organization in the coming days. The woman had ...

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO) Cancer is the second leading cause of death globally. However, by ...

Evidence regarding screening for atrial fibrillation (AF) in asymptomatic adults without a history of TIA/stroke remains insufficient to definitively weigh the potential benefits and harms, according ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance data for its blood-based colorectal cancer ...